Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Denmark
  4. Nasdaq Copenhagen
  5. Genmab A/S
  6. News
  7. Summary
    GMAB   DK0010272202

GENMAB A/S

(GMAB)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Genmab A/S : has published its Articles of Association

10/16/2020 | 10:19am EDT

Genmab A/S has published its Articles of Association dated October 07, 2020.

The Articles of Association can be found on Genmab's website: https://ir.genmab.com/genmab-news.

Contact:

Marisol Peron

Tel: +1 609 524 0065

Email: mmp@genmab.com

(C) 2020 Electronic News Publishing, source ENP Newswire

All news about GENMAB A/S
06/23GENMAB A/Sá : Announces that Janssen has Received European Marketing Authorizati..
AQ
06/22GENMAB A/Sá : Grant of Restricted Stock Units and Warrants to Employees in Genma..
PU
06/22GENMAB A/Sá : Grant of Restricted Stock Units and Warrants to Employees in Genma..
AQ
06/22GENMAB A/Sá : Partner Janssen Secures EU Approval for Darzalex SC Combo in Rare ..
MT
06/22Genmab Announces that Janssen has Received European Marketing Authorizations ..
GL
06/22GENMAB A/Sá : - Transactions in connection with share buy-back program
AQ
06/21GENMAB A/Sá : Transactions in connection with share buy-back program (Form 6-K)
PU
06/21GENMAB A/Sá : Transactions in connection with share buy-back program
AQ
06/18PRESS RELEASEá : BioNTech Announces First Patient Dosed in Phase 2 Clinical Tria..
DJ
06/16GENMAB A/Sá : Transactions with shares and linked securities in Genmab A/S made ..
PU
More news
Financials
Sales 2021 7 668 M 1 230 M 1 230 M
Net income 2021 2 035 M 327 M 327 M
Net cash 2021 14 830 M 2 380 M 2 380 M
P/E ratio 2021 87,5x
Yield 2021 -
Capitalization 171 B 27 448 M 27 415 M
EV / Sales 2021 20,3x
EV / Sales 2022 15,3x
Nbr of Employees 871
Free-Float 95,1%
Chart GENMAB A/S
Duration : Period :
Genmab A/S Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends GENMAB A/S
Short TermMid-TermLong Term
TrendsBullishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 23
Last Close Price 2 615,00 DKK
Average target price 2 425,00 DKK
Spread / Average Target -7,27%
EPS Revisions
Managers and Directors
NameTitle
Jan G. J. van de Winkel President & Chief Executive Officer
Anthony Pagano Chief Financial Officer & Executive Vice President
Deirdre P. Connelly Chairman
Tahamtan Ahmadi Chief Medical Officer & Executive Vice President
Anthony Mancini Chief Operating Officer & Executive Vice President
Sector and Competitors
1st jan.Capitalization (M$)
GENMAB A/S6.17%27 448
GILEAD SCIENCES, INC.14.40%83 591
WUXI APPTEC CO., LTD.36.51%69 433
BIONTECH SE181.53%55 429
REGENERON PHARMACEUTICALS9.66%54 864
VERTEX PHARMACEUTICALS-20.66%48 542